Khaled Y. Mahmoud, Yasmeen N. Ezzeldeen, Arwa A. Nasr, Mai O. Ghonim, Menna W. Ibrahim, Mohamed G. Ali, Mona A. Helmi, Nada A. Mostafa, Nada T. Abdelaziz, Naira N. Elmohandes, Yara H. Mahmoud, Shady A. Swidan
{"title":"Silibinin-loaded cubosomes: a gateway to enhanced hepatoprotective activity","authors":"Khaled Y. Mahmoud, Yasmeen N. Ezzeldeen, Arwa A. Nasr, Mai O. Ghonim, Menna W. Ibrahim, Mohamed G. Ali, Mona A. Helmi, Nada A. Mostafa, Nada T. Abdelaziz, Naira N. Elmohandes, Yara H. Mahmoud, Shady A. Swidan","doi":"10.1186/s43094-025-00828-0","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>The liver is a vital organ that detoxifies drugs and xenobiotics. However, breaking down toxins creates byproducts that can damage the liver. Silibinin possesses a proven hepatoprotective and antioxidant effect as it inhibits the free radicals produced from the metabolism of toxic substances, such as paracetamol and ethanol. Unfortunately, the poor bioavailability of silibinin hinders its use, which could be overcome by loading it into lipid nanocarriers, such as cubosomes. This study aims to formulate silibinin-loaded cubosomes and evaluate their hepatoprotective effect in vivo.</p><h3>Results</h3><p>A full factorial design was conducted to evaluate the percentage of poloxamer 407 and the sonication time. The prepared cubosomes were characterized by multiple characterization techniques. The in vitro release of silibinin from the chosen formulation was also evaluated. An induced acute paracetamol hepatotoxicity model in mice was utilized for in vivo evaluation. The particle size of the formulated cubosomes ranged from 123.2 to 210.9 nm, and the polydispersity index range was 0.226–0.560. The zeta potential of the formulations ranged between − 14.2 and − 25.6 mV. The chosen formulation displayed a controlled release pattern. The chosen formulation showed a significant hepatoprotective action by reducing the liver marker enzymes. The histopathological study also confirmed the hepatoprotective activity of the chosen cubosomes. The hepatoprotective effects of the chosen formulation can be attributed to positive impacts on oxidative stress, as demonstrated in oxidative stress markers.</p><h3>Conclusion</h3><p>The obtained results suggest that silibinin-loaded cubosomal formulation offers apotentially improved hepatoprotection effect against induced acute paracetamol hepatotoxicity.</p><h3>Graphical abstract</h3><div><figure><div><div><picture><source><img></source></picture></div></div></figure></div></div>","PeriodicalId":577,"journal":{"name":"Future Journal of Pharmaceutical Sciences","volume":"11 1","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00828-0","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Future Journal of Pharmaceutical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1186/s43094-025-00828-0","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
The liver is a vital organ that detoxifies drugs and xenobiotics. However, breaking down toxins creates byproducts that can damage the liver. Silibinin possesses a proven hepatoprotective and antioxidant effect as it inhibits the free radicals produced from the metabolism of toxic substances, such as paracetamol and ethanol. Unfortunately, the poor bioavailability of silibinin hinders its use, which could be overcome by loading it into lipid nanocarriers, such as cubosomes. This study aims to formulate silibinin-loaded cubosomes and evaluate their hepatoprotective effect in vivo.
Results
A full factorial design was conducted to evaluate the percentage of poloxamer 407 and the sonication time. The prepared cubosomes were characterized by multiple characterization techniques. The in vitro release of silibinin from the chosen formulation was also evaluated. An induced acute paracetamol hepatotoxicity model in mice was utilized for in vivo evaluation. The particle size of the formulated cubosomes ranged from 123.2 to 210.9 nm, and the polydispersity index range was 0.226–0.560. The zeta potential of the formulations ranged between − 14.2 and − 25.6 mV. The chosen formulation displayed a controlled release pattern. The chosen formulation showed a significant hepatoprotective action by reducing the liver marker enzymes. The histopathological study also confirmed the hepatoprotective activity of the chosen cubosomes. The hepatoprotective effects of the chosen formulation can be attributed to positive impacts on oxidative stress, as demonstrated in oxidative stress markers.
Conclusion
The obtained results suggest that silibinin-loaded cubosomal formulation offers apotentially improved hepatoprotection effect against induced acute paracetamol hepatotoxicity.
期刊介绍：
Future Journal of Pharmaceutical Sciences (FJPS) is the official journal of the Future University in Egypt. It is a peer-reviewed, open access journal which publishes original research articles, review articles and case studies on all aspects of pharmaceutical sciences and technologies, pharmacy practice and related clinical aspects, and pharmacy education. The journal publishes articles covering developments in drug absorption and metabolism, pharmacokinetics and dynamics, drug delivery systems, drug targeting and nano-technology. It also covers development of new systems, methods and techniques in pharmacy education and practice. The scope of the journal also extends to cover advancements in toxicology, cell and molecular biology, biomedical research, clinical and pharmaceutical microbiology, pharmaceutical biotechnology, medicinal chemistry, phytochemistry and nutraceuticals.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
